| |
|
|
| Name: |
RA CAPITAL MANAGEMENT LLC |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02199 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
38 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
PCVX |
Vaxcyte, Inc. |
3 |
- |
$0.00 |
$495,571,000 |
7,891,254 |
7.74% |
93,275,000 |
0 |
7.317 |
N/A |
|
|
LEGN |
Churchill Cap Corp Iii |
4 |
- |
$45.72 |
$376,947,000 |
6,264,707 |
5.89% |
-43,853,000 |
0 |
4.847 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
6 |
- |
$0.00 |
$187,014,000 |
8,263,982 |
2.92% |
74,872,000 |
0 |
31.173 |
N/A |
|
|
INBX |
Inhibrx, Inc. |
7 |
- |
$0.00 |
$179,520,000 |
4,724,207 |
2.8% |
92,831,000 |
0 |
12.528 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
8 |
- |
$32.48 |
$163,923,000 |
6,940,000 |
2.56% |
60,448,000 |
0 |
7.326 |
N/A |
|
|
BIIB |
Biogen Idec Inc |
9 |
- |
$219.72 |
$137,896,000 |
532,892 |
2.15% |
937,000 |
0 |
0.346 |
Biotechnology |
|
|
ETNB |
89bio, Inc. |
11 |
- |
$9.03 |
$127,527,000 |
11,416,948 |
1.99% |
-48,751,000 |
0 |
15.324 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
12 |
- |
$0.00 |
$125,602,000 |
6,317,990 |
1.96% |
22,619,000 |
0 |
8.613 |
N/A |
|
|
DAWN |
Day One Biopharmaceuticals,... |
13 |
- |
$0.00 |
$114,024,000 |
7,809,852 |
1.78% |
18,197,000 |
0 |
12.611 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
14 |
- |
$2.44 |
$113,746,000 |
5,551,295 |
1.78% |
24,481,000 |
0 |
28.6 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
15 |
- |
$0.00 |
$100,225,000 |
7,236,454 |
1.57% |
579,000 |
0 |
17.534 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
16 |
- |
$0.00 |
$98,347,000 |
9,165,652 |
1.54% |
5,957,000 |
0 |
22.972 |
N/A |
|
|
GERN |
Geron Corporation |
17 |
- |
$3.81 |
$97,487,000 |
46,202,425 |
1.52% |
-462,000 |
0 |
13.503 |
Drug Manufacturers - ... |
|
|
ICVX |
Icosavax, Inc. |
18 |
- |
$0.00 |
$93,986,000 |
5,963,565 |
1.47% |
47,768,000 |
0 |
15.14 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
22 |
- |
$0.00 |
$84,347,000 |
4,163,211 |
1.32% |
31,349,000 |
0 |
12.853 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
24 |
- |
$75.68 |
$79,590,000 |
1,000,000 |
1.24% |
9,700,000 |
0 |
2.678 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
25 |
- |
$0.00 |
$78,366,000 |
11,609,704 |
1.22% |
26,819,000 |
0 |
18.42 |
N/A |
|
|
ABOS |
Acumen Pharmaceuticals, Inc. |
27 |
- |
$0.00 |
$57,339,000 |
14,932,063 |
0.9% |
-4,629,000 |
0 |
36.897 |
N/A |
|
|
PEPG |
Pepgen Inc. |
28 |
- |
$13.70 |
$55,297,000 |
8,131,952 |
0.86% |
13,987,000 |
0 |
34.414 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
29 |
- |
$51.26 |
$55,263,000 |
1,977,901 |
0.86% |
13,134,000 |
0 |
5.318 |
N/A |
|
|
SBTX |
Silverback Therapeutics, Inc. |
30 |
- |
$0.00 |
$51,839,000 |
9,459,678 |
0.81% |
16,081,000 |
0 |
5.464 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
31 |
- |
$0.00 |
$51,514,000 |
7,805,129 |
0.8% |
40,665,000 |
0 |
16.04 |
N/A |
|
|
VOR |
Vor Biopharma Inc. |
32 |
- |
$0.00 |
$51,185,000 |
22,748,880 |
0.8% |
2,957,000 |
0 |
34.652 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
33 |
- |
$0.00 |
$48,369,000 |
4,417,259 |
0.76% |
0 |
0 |
11.637 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
34 |
- |
$208.04 |
$47,317,000 |
204,500 |
0.74% |
17,452,000 |
0 |
1.233 |
Diagnostic Substances |
|
|
ELYM |
Eliem Therapeutics, Inc. |
37 |
- |
$0.00 |
$35,507,000 |
13,150,849 |
0.55% |
920,000 |
0 |
49.532 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
38 |
- |
$0.00 |
$32,696,000 |
18,472,503 |
0.51% |
-25,677,000 |
0 |
49.939 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
39 |
- |
$0.00 |
$32,407,000 |
5,587,333 |
0.51% |
-23,746,000 |
0 |
11.438 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
40 |
- |
$0.00 |
$29,375,000 |
2,122,465 |
0.46% |
382,000 |
0 |
5.999 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
42 |
- |
$0.00 |
$27,335,000 |
3,178,476 |
0.43% |
-2,892,000 |
0 |
7.779 |
N/A |
|
|
HOWL |
Werewolf Therapeutics, Inc. |
43 |
- |
$0.00 |
$23,719,000 |
6,144,881 |
0.37% |
10,569,000 |
0 |
22.288 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
44 |
- |
$8.23 |
$23,668,000 |
4,810,508 |
0.37% |
-22,320,000 |
0 |
23.039 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
48 |
- |
$10.25 |
$21,037,000 |
3,426,286 |
0.33% |
12,403,000 |
0 |
17.517 |
N/A |
|
|
BCYC |
Bicycle Therapeutics Ltd |
53 |
- |
$0.00 |
$14,464,000 |
800,000 |
0.23% |
-1,608,000 |
0 |
2.72 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
55 |
- |
$0.00 |
$11,253,000 |
1,286,000 |
0.18% |
1,737,000 |
0 |
3.694 |
N/A |
|
|
BDTX |
Black Diamond Therapeutics,... |
56 |
- |
$6.94 |
$9,907,000 |
3,525,754 |
0.15% |
-212,000 |
0 |
9.794 |
N/A |
|
|
IGMS |
Igm Biosciences, Inc. |
58 |
- |
$0.00 |
$7,791,000 |
937,500 |
0.12% |
-37,000 |
0 |
3.871 |
N/A |
|
|
UNCY |
Unicycive Therapeutics, Inc. |
60 |
- |
$0.00 |
$3,012,000 |
3,470,688 |
0.05% |
27,000 |
0 |
23.919 |
N/A |
|
